America Great Health (AAGH)

[Penny Stocks 2.0]

Current Report Filing (8-k)Source: Edgar (US Regulatory)


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 2nd, 2018

 

America Great Health

(Exact name of registrant as specified in charter)


WYOMING

(State or other jurisdiction of incorporation)

 

0-27873

 

98-0178621

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

1609 W Valley Blvd., #338,

Alhambra, CA 91803

 

28277

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  [phone]

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

?     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

?     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

?     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

?     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1934 (§240.12b-2 of this chapter)

Emerging growth company ? .

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ? 


 

ITEM 4.01      Change in Registrant’s Certifying Accountant.

 

(a)    Dismissal of Independent Registered Public Accounting Firm.

NEW AUDITOR/AUDITED FINANCIALS JUNE 30/2018....On January 28 2018, America Great Health (the “Company ” ) dismissed TAAD LLP ( “ TAAD ” ) as the Company’s independent registered public accounting firm.


The TAAD reports on the Company ’ s financial statements for the years ended June 30, 2017 and 2016 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles.


During the Company ’ s years ended June 30, 2017 and 2016 and through January 28 2018, (i) there were no disagreements with TAAD on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to TAAD ’ s satisfaction, would have caused TAAD to make reference to the subject matter of such disagreements in its reports on our consolidated financial statements for such years, and (ii) there were no reportable events as defined in Item 304(a)(1)(v) of Regulation S-K.


The Company has provided TAAD with a copy of the foregoing disclosures and requested that TAAD furnish a letter to the Securities and Exchange Commission stating whether or not it agrees with the above statements. A copy of such letter is filed as Exhibit 16.1 to this Current Report on Form 8-K.


(b)    Engagement of New Independent Registered Public Accounting Firm.


On January 29, 2018, we engaged Sadler, Gibb & Associates, LLC ( “ Sadler Gibb ” ) as our independent registered public accounting firm to audit the Company ’ s consolidated financial statements as of June 30, 2018 and for the year then ended. Sadler Gibb will be performing reviews of the unaudited consolidated quarterly financial statements to be included in the Company ’ s quarterly reports on Form 10-Q for the year ended June 30, 2018 as well as going forward.


During each of the Company ’ s two most recent fiscal years and through the date of this report, (a) the Company has not engaged Sadler Gibb as either the principal accountant to audit the Company ’ s financial statements, or as an independent accountant to audit a significant subsidiary of the Company and on whom the principal accountant is expected to express reliance in its report; and (b) the Company or someone on its behalf did not consult Sadler Gibb with respect to (i) either: the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company ’ s financial statements, or (ii) any other matter that was either the subject of a disagreement or a reportable event as set forth in Items 304(a)(1)(iv) and (v) of Regulation S-K.


ITEM 9.01      Financial Statements and Exhibits.

 

Exhibit 16.1:     Letter from TAAD LLP dated Feburary 2, 2018 to the Securities and Exchange Commission.


 





SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed by the undersigned hereunto duly authorized.


                         

AMERICA GREAT HEALTH

Date: February 2 nd , 2018                        

By:      /s/ Mike Wang                

Name:    Mike Wang

Title:      President